Bitget App
Trade smarter
MarketsTradeFuturesEarnAISquareMore
Biontech Insider Sold Shares Worth $4,721,976, According to a Recent SEC Filing

Biontech Insider Sold Shares Worth $4,721,976, According to a Recent SEC Filing

MT newswireMT newswire2026/09/16 21:08
05:08 PM EDT, 09/16/2026 (MT Newswires) -- Ugur Sahin, 10% Owner, Chief Executive Officer, on September 15, 2026, sold 49,000 shares in Biontech (BNTX) for $4,721,976. Following the Form 4 filing with the SEC, Sahin has control over a total of 39,771,320 ordinary shares of the company, with 553,209 shares held directly and 39,218,111 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1776985/000212397526000017/xslF345X05/wk-form4_1789591576.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

The $50 billion target falls short, Salesforce (CRM.US) draws another $63 billion blueprint—can it convince Wall Street that the “AI replacement theory” is exaggerated?

Salesforce announced an ambitious FY2030 revenue target of $63 billions, surpassing expectations, and is rebuilding market confidence in its strategy by strengthening its partnership with Anthropic to ease concerns over AI competition.

智通财经2026/09/17 01:06
The $50 billion target falls short, Salesforce (CRM.US) draws another $63 billion blueprint—can it convince Wall Street that the “AI replacement theory” is exaggerated?